Novel Concepts Medical Overview
Novel Concepts Medical is a research and development company that produces formulas and treatments based on natural compounds. The company specializes in the areas of respiratory diseases, Alzheimers disease, cancer, obesity, diabetes, and anemia.
Latest News
growth-positive
A Triplet Breakthrough for Novel Concepts Medical: Stopped COVID-19, the Omicron Variant, and Long COVID-19 Symptoms, Including Memory Loss
Startup company Novel Concepts Medical has made a major breakthrough in its research of COVID-19. Its plant-based treatment has successfully inhibited the COVID-19 Omicron variant and blocked its connection to human cells. The treatment has shown promising results in stopping the viruss entry to cells and reducing symptoms of long COVID-19. The company is welcoming emergency testing requests from all countries and plans to hold an initial public offering in 2022. The research was conducted in collaboration with the Centre for Microbial Chemical Biology at McMaster University in Canada and the Smart Assays Lab in Israel.
CustomersPublic Trading
growth-positive
https://www.jpost.com/business-and-innovation/article-695915
Israeli medical startup Novel Concepts claims to have developed a plant-based COVID-19 treatment that can stop the attachment of the virus, including the Omicron variant, to human cells. The treatment has shown promising results in stopping the progression of the virus and reducing long-COVID symptoms. Novel Concepts is welcoming emergency testing requests from multiple countries and plans to submit the treatment for emergency use authorization. The companys findings can be viewed on its website. The treatment is made of natural compounds that are individually approved for other uses and can be stored at room temperature, making it easier to transport. Novel Concepts plans to hold an IPO in 2022.
CustomersPublic Trading
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | novelconceptsmedical.com |
| Careers | Careers page |
Locations
Berkovitch Street 4, Tel Aviv-Yafo, Israel
Photos & Videos
1 item(s)
Novel Concepts Medical Business
Business models
B2C, B2B
Product stage
Clinical Trial
Employees
1-10
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyCore Technology
BiologicalsHerbalsTags (12)
obesitycancerpatent-pendingdiabetestreatmentspharmaceuticalssupplementsasthmabiotechnologyalzheimers-diseaserespiratorybiopharmaceuticalGeographic Markets
IsraelNovel Concepts Medical Financials
Undisclosed
Total funding
—
Capital raised
Undisclosed
Last funding
Pre-Funding
Funding stage
0
Total rounds
0
Investors
Novel Concepts Medical Lifecycle
Novel Concepts Medical News
2 articles
growth-positive
A Triplet Breakthrough for Novel Concepts Medical: Stopped COVID-19, the Omicron Variant, and Long COVID-19 Symptoms, Including Memory Loss
Startup company Novel Concepts Medical has made a major breakthrough in its research of COVID-19. Its plant-based treatment has successfully inhibited the COVID-19 Omicron variant and blocked its connection to human cells. The treatment has shown promising results in stopping the viruss entry to cells and reducing symptoms of long COVID-19. The company is welcoming emergency testing requests from all countries and plans to hold an initial public offering in 2022. The research was conducted in collaboration with the Centre for Microbial Chemical Biology at McMaster University in Canada and the Smart Assays Lab in Israel.
CustomersPublic Trading
growth-positive
https://www.jpost.com/business-and-innovation/article-695915
Israeli medical startup Novel Concepts claims to have developed a plant-based COVID-19 treatment that can stop the attachment of the virus, including the Omicron variant, to human cells. The treatment has shown promising results in stopping the progression of the virus and reducing long-COVID symptoms. Novel Concepts is welcoming emergency testing requests from multiple countries and plans to submit the treatment for emergency use authorization. The companys findings can be viewed on its website. The treatment is made of natural compounds that are individually approved for other uses and can be stored at room temperature, making it easier to transport. Novel Concepts plans to hold an IPO in 2022.
CustomersPublic Trading
Novel Concepts Medical Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 5 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
Novel Concepts Medical Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 82/100 |
| Missing | description, funding rounds, markets, not claimed |
| BI Verification | Yotam Maman |
| Phone | +97236935242 |
| Creator | Matan Eblagon |
| Creator email | matane@sncentral.org |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2022-03-17T00:00:00.000Z |
| Created | 2022-03-17T00:00:00.000Z |